Mandate

Vinge Advises Cyril Acquisitions in Offer for Cision

May 07, 2008

Cyril Acquisition AB, owned by Triton Fund II, has made official an offer to acquire all shares in Cision AB. Cyril Acquisition offer SEK 20 in cash for each share, and SEK 33,94 for each convertible profit share. Cision is listed on the OMX Nordic Exchange Stockholm AB, Mid Cap. Vinge has acted as the principal advisor in the transaction and handled the legal aspects connected to corporate law, finance, competition and due diligence.
 
Vinge's team included partner Johan Cederlund, Christina Kokko and Michael Ståhl, joined by associates Pontus Enquist and Petter Elmstedt concerning corporate issues, Sara Axelsson concerning financial issues, Björn Petersson in labour affairs, and Peter Forsberg and Hanna Eklinder regarding competition issues. Mi Gustafsson, Per Larsson and Tina Hård was engaged in the due diligence process.

Related

Vinge has advised Cinclus Pharma in connection with entering into financing agreement

Vinge has advised Cinclus Pharma Holding AB (publ), a late-stage clinical pharmaceutical company developing next-generation treatments for gastric acid-related diseases listed on Nasdaq Stockholm, in connection with a long-term structured credit agreement for a total of up to EUR 28 million divided into four tranches, of which two are convertibles.
March 16, 2026

Vinge has advised Skeptiva AB in connection with its financing round

Skeptiva is developing the next generation of cybersecurity defenses against fraud. The company has developed an AI application that detects attacks and alerts users in real time.
March 11, 2026

Vinge has advised Main Capital in connection with the acquisition of Good Solutions Sweden AB

Good Solutions Sweden AB (”Good Solutions”) provides software that helps factories identify and reduce production losses. The software converts data from machines and operators into insights that can be used to streamline production and increase profitability.
March 11, 2026